• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER, INC. TALAR COMPONENT BLUE SIZE 3 LEFT; PROSTHESIS, ANKLE, SEMI-CONSTRAINED, CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER, INC. TALAR COMPONENT BLUE SIZE 3 LEFT; PROSTHESIS, ANKLE, SEMI-CONSTRAINED, CEMENTED Back to Search Results
Model Number N/A
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Pain (1994); Swelling (2091); Anxiety (2328); Discomfort (2330); Depression (2361); Ambulation Difficulties (2544); Limited Mobility Of The Implanted Joint (2671)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is number 2 of 3 mdrs filed for the same patient (reference 0001822565-2017-04495 / 0001822565-2017-04497.Concomitant devices : palacos bone cement catalog # 00-1118-140-01, lot # 74704314, zimmer ankle tibial base size 3 catalog # 00450004300, lot number # 77003690, zimmer prolong tibial insert sz 3 +0 catalog # 00450005300, lot number # 62267028.The complaint device is not expected for return currently, but a supplemental medwatch 3500a will be submitted upon receipt of additional information.
 
Event Description
It was reported that a patient underwent a left ankle procedure.On the day of the procedure, mild tarsal/tibial neuritis was noted, and the patient underwent an injection approximately two (2) months post-operatively to treat the issue.This was reported to be not device related, but related to the procedure.Subsequently, mechanical signs of clicking and locking, an abnormal neurovascular assessment without functional limitation or pain, some problems with performing usual daily activities, some mobility issues, and moderate pain or discomfort were noted at six (6) week post-operative follow-up.Six (6) month post-operative follow-up noted: mild swelling, moderate tenderness, some mobility problems and some problems with performing daily usual activities, and severe pain/discomfort.At one (1) year post-operative follow, some mobility problems and problems with performing daily usual activities and severe pain/discomfort were noted.At two (2) year post-operative follow-up, some mobility problems and problems with performing daily usual activities and severe pain/discomfort were noted.Radiographic radiolucency was also noted at two (2) year post-operative follow-up.Attempts have been made to obtain additional information and further information is not available at this time.
 
Manufacturer Narrative
If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that a patient underwent a left ankle procedure.On the day of the procedure, mild tarsal/tibial neuritis was noted, and the patient underwent an injection approximately two (2) months post-operatively to treat the issue.This was reported to be not device related.Subsequently, mechanical signs of clicking and locking, an abnormal neurovascular assessment without functional limitation or pain, some problems with performing usual daily activities, some mobility issues, and moderate pain or discomfort were noted at six (6) week post-operative follow-up.Six (6) month post-operative follow-up noted: mild swelling, moderate tenderness, some mobility problems and some problems with performing daily usual activities, and severe pain/discomfort.At one (1) year post-operative follow, some mobility problems and problems with performing daily usual activities and severe pain/discomfort were noted.At two (2) year post-operative follow-up, some mobility problems and problems with performing daily usual activities and severe pain/discomfort were noted.Radiographic radiolucency that was related to the patient¿s medical condition, was also noted at two (2) year post-operative follow-up.
 
Manufacturer Narrative
This follow-up report is being submitted to relay additional information.Reported event was unable to be confirmed due to limited information received from the customer.Dhr was reviewed and no discrepancies relevant to the reported event were found.Review of the complaint history determined that no further action is required as no were trends identified.There are warnings in the package insert that this type of event can occur and risks are addressed in risk documentation.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TALAR COMPONENT BLUE SIZE 3 LEFT
Type of Device
PROSTHESIS, ANKLE, SEMI-CONSTRAINED, CEMENTED
Manufacturer (Section D)
ZIMMER, INC.
1800 west center street
warsaw IN 46580
Manufacturer (Section G)
ZIMMER, INC.
1800 west center street
warsaw IN 46580
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key6680674
MDR Text Key78811382
Report Number0001822565-2017-04496
Device Sequence Number1
Product Code HSN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PK120906
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Model NumberN/A
Device Catalogue Number00450001300
Device Lot Number77003664
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/31/2017
Initial Date FDA Received06/30/2017
Supplement Dates Manufacturer Received09/26/2017
10/13/2017
Supplement Dates FDA Received10/03/2017
10/13/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/04/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age71 YR
Patient Weight73
-
-